
TY  - JOUR
TI  - Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 16
IS  - s1
SN  - 1756-1841
UR  - https://doi.org/10.1111/1756-185X.12173
DO  - doi:10.1111/1756-185X.12173
SP  - 1
EP  - 122
PY  - 2013
ER  - 

TY  - JOUR
AU  - Möckel, Martin
AU  - de Boer, Rudolf A.
AU  - Slagman, Anna Christine
AU  - von Haehling, Stephan
AU  - Schou, Morten
AU  - Vollert, Jörn Ole
AU  - Wiemer, Jan C.
AU  - Ebmeyer, Stefan
AU  - Martín-Sánchez, F. Javier
AU  - Maisel, Alan S.
AU  - Giannitsis, Evangelos
TI  - Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - n/a
IS  - n/a
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.1667
DO  - doi:10.1002/ejhf.1667
KW  - Acute heart failure
KW  - Procalcitonin
KW  - Natriuretic peptides
KW  - Antibiotic therapy
KW  - Mortality
AB  - Aim To determine whether initiation of antibiotic therapy (ABX) by procalcitonin (PCT) within 8 h of admission in patients presenting to the emergency department with symptoms and signs of acute heart failure (AHF) and elevated natriuretic peptides would improve clinical outcomes. Methods and results The study was a randomized multicentre clinical trial conducted at 16 sites in Europe. Patients were randomized to either a PCT-guided strategy or standard care. Patients with PCT-guided strategy (n =?370) had ABX initiated if PCT was >?0.2 ?g/L. Patients with standard care (n =?372) had AHF care in accordance with published guidelines without PCT. The primary endpoint was 90-day all-cause mortality. Pre-specified secondary endpoints included 30-day all-cause mortality and readmission and rate of pneumonia. The Data Safety and Review Committee recommended stopping the study for futility when 762 of the planned 792 patients had been enrolled. A total of?742 patients could be analysed. Patients were elderly (median age: 77?years), 38% were women, and had typical signs and symptoms of AHF. All-cause mortality at 90?days was 10.3% in the PCT-guided group vs. 8.2% in standard care (P =?0.316). Thirty-day readmission was significantly higher in the PCT-guided group vs. standard care but the difference vanished until day 90. The rate of pneumonia was overall low (7.5%) and not different between groups. Conclusions In patients with AHF, a strategy of PCT-guided initiation of ABX was not more effective than a standard care strategy in improving clinical outcomes.
ER  - 

TY  - JOUR
TI  - Program & Abstracts
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 17
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650170102
DO  - doi:10.1002/jbmr.5650170102
SP  - S1
EP  - S502
PY  - 2002
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Fundamental & Clinical Pharmacology
VL  - 25
IS  - s1
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.2011.00930.x
DO  - doi:10.1111/j.1472-8206.2011.00930.x
SP  - 1
EP  - 111
PY  - 2011
ER  - 

TY  - JOUR
TI  - Workshops
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 46
IS  - S1
SN  - 0014-2972
UR  - https://doi.org/10.1111/eci.12604
DO  - doi:10.1111/eci.12604
SP  - 6
EP  - 119
PY  - 2016
ER  - 

TY  - JOUR
TI  - SIOP 2013 Scientific Programme + Index
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 60
IS  - S3
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.24719
DO  - doi:10.1002/pbc.24719
SP  - S1
EP  - S264
PY  - 2013
ER  - 

TY  - JOUR
TI  - 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 61
IS  - S2
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.25314
DO  - doi:10.1002/pbc.25314
SP  - S105
EP  - S433
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts for Australian Gastroenterology Week 1998 20–23 October 1998, Canberra, Australia
JO  - Journal of Gastroenterology and Hepatology
VL  - 13
IS  - S2
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.1998.13.s2.108
DO  - doi:10.1111/jgh.1998.13.s2.108
SP  - A108
EP  - A208
PY  - 1998
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 26
IS  - S1
SN  - 0906-6705
UR  - https://doi.org/10.1111/exd.13298
DO  - doi:10.1111/exd.13298
SP  - 3
EP  - 38
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Nephrology
JA  - Nephrology
VL  - 24
IS  - S2
SN  - 1320-5358
UR  - https://doi.org/10.1111/nep.13651
DO  - doi:10.1111/nep.13651
SP  - 35
EP  - 43
PY  - 2019
ER  - 

TY  - JOUR
TI  - Concurrent, Oral, Poster, and Video Sessions
JO  - Diseases of the Esophagus
JA  - Dis Esophagus
VL  - 25
IS  - S1
SN  - 1120-8694
UR  - https://doi.org/10.1111/j.1442-2050.2012.01405.x
DO  - doi:10.1111/j.1442-2050.2012.01405.x
SP  - 33A
EP  - 180A
PY  - 2012
ER  - 

TY  - JOUR
TI  - Paper Abstracts
JO  - Journal of the American Geriatrics Society
VL  - 54
IS  - S4
SN  - 0002-8614
UR  - https://doi.org/10.1111/j.1532-5415.2006.00783.x
DO  - doi:10.1111/j.1532-5415.2006.00783.x
SP  - S1
EP  - S203
PY  - 2006
ER  - 

TY  - JOUR
TI  - ACTS Abstracts
JO  - Clinical and Translational Science
JA  - Clinical And Translational Science
VL  - 8
IS  - 3
SN  - 1752-8054
UR  - https://doi.org/10.1111/cts.12290
DO  - doi:10.1111/cts.12290
SP  - 178
EP  - 258
PY  - 2015
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Respirology
VL  - 13
IS  - s5
SN  - 1323-7799
UR  - https://doi.org/10.1111/j.1440-1843.2008.01430.x
DO  - doi:10.1111/j.1440-1843.2008.01430.x
SP  - A139
EP  - A208
PY  - 2008
ER  - 

TY  - JOUR
TI  - 39th Annual Meeting of the International Continence Society San Francisco, USA 29 September – 3 October, 2009
JO  - Neurourology and Urodynamics
JA  - Neurourol. Urodyn.
VL  - 28
IS  - 7
SN  - 0733-2467
UR  - https://doi.org/10.1002/nau.20808
DO  - doi:10.1002/nau.20808
SP  - 567
EP  - 935
PY  - 2009
ER  - 

TY  - JOUR
AU  - Dawson, Peter
AU  - Punwani, Shonit
TI  - NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis: Non-Gadolinium Options for the Imaging of CKD/ESRD Patients
JO  - Seminars in Dialysis
VL  - 21
IS  - 2
SN  - 0894-0959
UR  - https://doi.org/10.1111/j.1525-139X.2007.00401.x
DO  - doi:10.1111/j.1525-139X.2007.00401.x
SP  - 160
EP  - 165
PY  - 2008
AB  - Abstract Nephrogenic systemic fibrosis (NSF) is a severe systemic disorder developing apparently exclusively in patients in advanced renal failure who receive a gadolinium chelate contrast-enhancing agent for magnetic resonance imaging. Some other apparent risk factors have been identified but their status remains uncertain. Physicians are frequently confronted with patients at risk of NSF who need imaging. An approach to planning imaging in patients at risk to develop NSF is outlined.
ER  - 

TY  - JOUR
TI  - ASGBI abstracts 2009 Poster presentations
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 96
IS  - S4
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.6641
DO  - doi:10.1002/bjs.6641
SP  - 82
EP  - 182
PY  - 2009
AB  - Abstract The Annual Scientific Meeting of the Association of Surgeons of Great Britain and Ireland takes place this year at the Scottish Exhibition and Conference Centre, Glasgow, UK (13th?15th May 2009), under the presidency of Professor Michael Horrocks. To view the abstracts from this meeting, please click the pdf link on this page. Copyright ? 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Clinical care and other categories posters: Audit
JO  - Diabetic Medicine
VL  - 26
IS  - s1
SN  - 0742-3071
UR  - https://doi.org/10.1111/j.1464-5491.2009.02663.x
DO  - doi:10.1111/j.1464-5491.2009.02663.x
SP  - 79
EP  - 199
PY  - 2009
ER  - 

TY  - JOUR
TI  - Joint meeting of The Pathological Society of Great Britain and Ireland and the Dutch Pathological Society (NVvP) 186th Meeting of The Pathological Society of Great Britain and Ireland, Hosted by the Department of Pathology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands, 6–9 July 2004
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 204
IS  - S1
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.1770
DO  - doi:10.1002/path.1770
SP  - 1A
EP  - 54A
PY  - 2004
ER  - 

TY  - JOUR
TI  - Special issue abstracts from the 34th annual meeting of the American Society for Apheresis, May 22–25, 2013 Denver, Colorado
JO  - Journal of Clinical Apheresis
JA  - J. Clin. Apheresis
VL  - 28
IS  - 2
SN  - 0733-2459
UR  - https://doi.org/10.1002/jca.21272
DO  - doi:10.1002/jca.21272
SP  - 87
EP  - 141
PY  - 2013
ER  - 
